Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prion locus lncRNA, testis expressed (PRNT) is a human gene encoding a long non-coding RNA (lncRNA) that is primarily expressed in the testis[1][3][5]. It is annotated by the HUGO Gene Nomenclature Committee (HGNC) and located on chromosome 20q (chr20:4,731,282-4,740,668, hg38)[1][5][7][8]. Despite historical associations with names like "Putative testis-specific prion protein" and "M8," current genomic databases clearly define PRNT as a non-coding RNA rather than a protein-coding gene[1][3][5][7]. There is no compelling evidence for a protein product or known disease association, drug interactions, or role as a therapeutic target[1][3][6][8]. No molecular or clinical function has yet been established in the scientific literature, and it is not characterized as a receptor, enzyme, transporter, or classical therapeutic target. The gene is sometimes confused with prion protein (PRNP) or with the concept of testis-specific proteins, but it is distinct and encodes an lncRNA. Note: - The inclusion of protein-centric aliases like "Putative testis-specific prion protein" or "Protein M8" is legacy terminology. Updated sources confirm PRNT is an lncRNA without a proven protein product[1][3][4][7]. - As such, PRNT is not considered a therapeutic target and should not be classified under targetable receptors, enzymes, or protein families[6][8]. - Its function, if any, remains to be elucidated. Summary assessment: PRNT is a non-coding RNA gene, not a conventional drug target or protein, and its historical protein aliases reflect outdated or speculative annotations.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prion locus lncRNA, testis expressed (PRNT).